4
Changes in Ownership
Serina Therapeutics, Inc. Filed Acc 0001708599-25-000067
Chief Scientific Officer sold 6,500 shares at $5.78 ($37,570)
- Chief Scientific Officer acquired 6,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moreadith Randall Chief Scientific Officer | 2025-06-30 | Option exercise 10b5-1 | +6,500 | $0.06 | $390 | 6,500 | D: show line 1 in the form |
| Moreadith Randall Chief Scientific Officer | 2025-06-30 | Sale 10b5-1 | −6,500 | $5.78 | $37,570 | 0 | D: show line 2 in the form |
| Open-market sales · 6,500 sh · avg $5.78 · $37,570 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Moreadith Randall Chief Scientific Officer | 2025-06-30 | Option exercise · Stock Option (right to buy) 10b5-1 | −6,500 | 514,686 | D: show line 3 in the form |
Loading xslF345X05/wk-form4_1751468419.xml…